Cipher Pharmaceuticals Earlier Announced Its New Drug Submission For PLECANATIDE Has Been Accepted For Review By Health Canada; Cipher In February Acquired The Canadian Rights To PLECANATIDE From Synergy Pharmaceuticals
Benzinga Newsdesk